Pharmacoeconomic considerations for inflammatory bowel disease in the era of biological therapies.
Thomas T, Cohen RD. Pharmacoeconomic considerations for inflammatory bowel disease in the era of biological therapies. Expert Rev Gastroenterol Hepatol. 2007 Oct; 1(1):101-12.